PHIO
Phio Pharmaceuticals Corp
Stock NASDAQ – Stock Market Prices, News & Analysis
Phio Pharmaceuticals is a biotechnology company that develops innovative immuno-oncology treatments utilizing RNA interference technology to enhance the immune defenses against cancer.
Phio Pharmaceuticals Corp
PHIO
Phio Pharmaceuticals is a biotechnology company that develops innovative immuno-oncology treatments utilizing RNA interference technology to enhance the immune defenses against cancer.
Price history of Phio Pharmaceuticals Corp
Price history of Phio Pharmaceuticals Corp
Performance & Momentum
Strategic Analysis
Phio Pharmaceuticals Corp • 2026
Phio Pharmaceuticals is developing innovative immuno-oncology therapies centered on RNA interfaces, a niche area with high potential in the fight against cancer. Its model is based on advanced biotechnology research aimed at enhancing specific immune responses, positioning it within a highly specialized and competitive segment of the healthcare sector.
- Innovative technological approach using RNA to modulate the immune system
- Targeted focus on oncology, a promising segment with high added value
- Expertise in next-generation therapies in immuno-oncology
- Severely degraded long-term financial and stock performance
- Lack of recent positive signals to reverse the negative trend
The momentum is very weak with no notable improvement, reflecting a loss of investor confidence and high volatility. The absence of a recent catalyst makes a recovery unlikely in the short term, necessitating strong caution for retail investors.
Similar stocks to Phio Pharmaceuticals Corp
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
